# OLI Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oli-technologies

- Industry: Medical Devices & Equipment
- Headquarters: North Brunswick, US
- Website: www.oli.inc
- Total disclosed funding: $0.7M
- Latest round: Seed (Feb 7, 2025)
- Investors on record: 2

## About

OLI Technologies, Inc. develops innovative home hemodialysis solutions, enhancing patient autonomy and clinical outcomes for individuals with chronic kidney disease, allowing them to conduct treatment within their own homes. OLI Technologies, Inc. is focused on providing advanced home hemodialysis solutions. The company was founded in 2021 in North Brunswick, US. In February 2025, OLI Technologies, Inc. raised USD 0.70 million in seed funding led by new investor Verge HealthTech Fund and returning investor SOSV. Other unspecified investors also participated in the round. OLI Technologies, Inc. specializes in advanced home hemodialysis solutions, targeting a niche market within the healthcare sector focused on providing patients with the ability to perform dialysis in the comfort of their own homes. The core product offering revolves around a proprietary hemodialysis system designed to enhance patient autonomy and improve clinical outcomes. This innovative system caters to individuals suffering from chronic kidney disease, addressing critical issues such as accessibility to treatment and the quality of life. OLI’s solutions are primarily aimed at patients across North America and select markets in Europe, with a focus on both private payers and partnerships with healthcare providers. The company emphasizes a user-friendly experience, equipping patients with the necessary tools and support to manage their treatment effectively at home. OLI Technologies generates revenue through a structured model that includes direct-to-consumer sales and partnerships with healthcare providers. The firm offers various subscription plans for its home hemodialysis systems, providing patients with ongoing access to equipment and essential supplies. Revenue streams are augmented by the sale of consumable products associated with their flagship hemodialysis system, which are necessary for ongoing treatment. Customer transactions typically involve initial setup costs, followed by recurring fees for consumables, ensuring a steady cash flow from both individual patients and healthcare institutions. This financial structure supports OLI’s commitment to delivering comprehensive and continuous care to its client base. The company will use the August 2025 funding for further growth and development.

## Funding rounds

- Seed, Feb 7, 2025, $0.7M — SOSV, Verge HealthTech

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- Verge HealthTech (https://capitalatlas.ai/funds/verge-healthtech) — Seed